Potential COVID-19 treatment to wrap up Phase III trial
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.
Source: outsourcing-pharma.com
Page 43 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Linical Evolution Today - Breaking & Trending Today
Potential COVID-19 treatment to kick off Phase III trial
Appili Therapeutics reports it has enrolled the last patient for its Phase III study of Avigan/Reeqonus (favipiravir), developed in alliance with AiPharma.
Source: outsourcing-pharma.com
Survey: pandemic viewed as catalyst for positive change
According to a recent survey from Oracle Health Sciences, 97% of trial professionals say newly adopted approaches will stay in use as we move beyond COVID-19.
Source: outsourcing-pharma.com
Speaking the language of diverse patient populations is vital
A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.
Source: outsourcing-pharma.com
BBK Worldwide clinical travel program hits 20,000 trips
RSG Arrive is intended to increase clinical trial participation by offering ground transport, plane rides, hotels, visa procurement, and other services.
Source: outsourcing-pharma.com